       Document 0118
 DOCN  M9590118
 TI    [Investigation of mortality among HIV-infected intravenous drug users in
       Ruili region of Yunnan province]
 DT    9509
 AU    Duan YJ; Zheng XW; Zhen CH; Ruili Municipal Sanitary & Anti-Epidemic
       Station, Yunnan; Province.
 SO    Chung Hua Liu Hsing Ping Hsueh Tsa Chih. 1995 Apr;16(2):71-3. Unique
       Identifier : AIDSLINE MED/95300203
 AB    The investigation of death condition of HIV infected intravenous drug
       users (IVDU) was conducted with a retrospective cohort study in Ruili
       city of Yunnan province from 1989-Oct to 1993-Oct, the deaths among 395
       HIV+ IVDUs add up to 61 and the mortality is 15.4%, which has
       significant difference compared to the death level of control cohort
       composed by 192 HIV- IVDUs (add up to 18). The relative risk of death is
       1.6 (95% confidence interval 1.0-2.5). After classified by the cause of
       death, it was found that both maintain high accidence mortality caused
       mainly by narcotism, violence and suicide. But in death group caused by
       diseases, the mortality of HIV+ IVDU (8.4%) is much higher than HIV-
       IVDU (3.1%) (95% confidence interval 1.2-6.1). We also compared non-AIDS
       mortality between HIV+ and HIV- IVDU according to data of HIV/AIDS
       surveillance which showed 2 patients died of AIDS in HIV+ IVDU. The
       difference is also significant (13.8% in HIV+, but 7.9% in HIV- IVDU)
       and the relative risk is 1.7 (95% confidence interval 1.0-2.8). The
       results indicated that the lever of reported AIDS cases were probably
       lower than that of actual AIDS cases existing.
 DE    Adult  Cause of Death  China/EPIDEMIOLOGY  Cohort Studies  Comparative
       Study  English Abstract  Female  Human  HIV Infections/*MORTALITY  HIV
       Seropositivity/MORTALITY  Male  Retrospective Studies  Substance Abuse,
       Intravenous/*MORTALITY  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).

